Pediatrix Medical Group (MD) presents a deeply negative liquidation posture driven by the asymmetry between a largely intangible asset base and face-value liabilities. At March 31, 2026, MFFAIS reports a cash liquidation value of approximately -$264M and a liquid liquidation value of approximately -$39M, both negative, consistent with the balance sheet composition described below. Total assets of $2.07B are dominated by goodwill of $1.27B (61% of total assets) and finite-lived intangibles of $15.9M, both assigned zero recovery under the liquidation lens. Tangible assets with meaningful recovery potential are limited: cash and equivalents of $205.8M (100% recovery), accounts receivable of $224.8M (90-95% haircut = ~$202-213M), available-for-sale securities of $123.2M (near-100% if liquid), net PP&E of $41.1M (50-70% = ~$21-29M), and deferred tax assets of $65.7M (limited liquidation value, likely zero in practice). Against these, the liability stack carried at face value includes $590.8M in total debt ($192.4M current portion of Term A Loan plus $398.3M long-term, primarily the $400M 5.375% 2030 Notes), operating lease liabilities of $38.9M ($11.9M current + $27.1M non-current), malpractice loss contingency accruals of $270.9M ($34.0M current + $237.0M non-current), current accounts payable and accrued expenses of $236.9M, and other non-current liabilities of $86.7M ($57.0M deferred tax liability + $29.7M other). The malpractice liability is a critical liquidation-adverse item: the filing discloses total professional liability reserves of $270.9M, which do not extinguish on wind-up. This liability is notably not fully tagged in XBRL on a combined basis; the current and non-current portions appear separately under MalpracticeLossContingencyAccrualUndiscountedCurrent and MalpracticeLossContingencyAccrualUndiscountedNoncurrent. A material near-term refinancing risk exists: the Amended Credit Agreement (Term A Loan, $190.6M outstanding) matures February 11, 2027, with a bullet payment of $171.9M due at maturity. This creates significant current liability reclassification; the $192.4M current debt balance reflects this. Cash declined from $375.2M at December 31, 2025 to $205.8M at March 31, 2026, a $169.5M decrease, primarily from the Q1 pattern of large annual physician incentive compensation payments ($155.3M net decrease in accrued salaries). This is a recurring seasonal pattern, not a one-time deterioration, but it does compress near-term liquidity. Working capital fell from $304.6M to $144.4M QoQ, driven by Term A Loan reclassification to current. Goodwill increased $7.5M from a single maternal-fetal medicine acquisition closed March 20, 2026 for $7.9M total consideration, adding incremental zero-recovery intangible value. The 2030 Notes at $400M face value remain the dominant fixed-rate unsecured obligation and represent the single largest liability item after malpractice reserves.
▼ Community Notes